CLINICAL SOLUTIONS EXIST BUT SYSTEMS FAIL TO DELIVER

For Immediate Release — August 2026

GENEVA — The World Health Organization's Global Oral Health Action Plan 2023-2030 begins with a number: 350 million. That is the estimated number of adults worldwide living with complete edentulism — having lost all of their natural teeth. It is a figure that exceeds the entire population of the United States, and it is growing every year as the world's population ages.

The clinical evidence on how to serve these patients has never been stronger. Material science has produced flexible thermoplastic denture bases, advanced soft liners, and high-impact acrylics that make conventional complete dentures more comfortable and durable than any prior generation of prosthetics. Mini dental implant systems have reduced the cost of implant-supported overdentures by 40 to 60 percent compared to conventional protocols. Two-implant mandibular overdentures — a treatment supported by overwhelming clinical evidence and endorsed by every major prosthodontic organization globally — can transform the lives of edentulous patients at a cost that national health systems can sustain.

And yet the systems delivering these solutions to the patients who need them are failing at scale.

Behind the global statistics lies a human reality that resists quantification.

In the United States, an estimated 15 to 25 percent of adults over the age of 65 have lost all their natural teeth. Rates are substantially higher among lower-income populations and racial and ethnic minorities who have historically faced structural barriers to preventive and restorative dental care. The problem is not that the clinical solutions are unknown — it is that reaching the patients who need them requires systems, coverage, workforce, and infrastructure that do not currently exist at sufficient scale.

In Western Europe, national health systems offer varying levels of coverage for complete dentures, creating a patchwork of access that often reflects income rather than clinical need. The United Kingdom's National Health Service provides subsidized complete denture services through registered dental laboratories — a model that ensures baseline access for pensioners — but capacity constraints mean long waiting times and variable quality. Germany's statutory health insurance covers standard complete dentures, yet patient demand for premium prosthetic options continues to shift costs onto individuals.

In the Asia-Pacific region, the demographic pressure is most acute. China, with over 300 million citizens aged 60 and above, faces a collision between a rapidly aging population and a prosthetic dental infrastructure that expanded unevenly across a vast geography. India and Southeast Asian nations face similar pressures with significantly fewer resources per capita allocated to prosthetic dental care.

In Sub-Saharan Africa and South Asia, the burden falls hardest on the populations least equipped to access any form of prosthetic rehabilitation. Trained prosthodontists are scarce. Materials are expensive to import. Public dental coverage, where it exists at all, rarely extends to complete denture fabrication. For millions of edentulous patients in these regions, going without a functional prosthesis is not a treatment choice — it is the only option available.

Three developments are converging to reshape the economics of edentulous rehabilitation globally.

First, national volume-based procurement programs are demonstrating that the cost of dental implants can be reduced substantially without compromising quality. China's national implant procurement initiative, launched in April 2023, reduced prices by approximately 55 percent — a demonstration that coordinated public purchasing can expand the patient population for whom implant-based rehabilitation is economically feasible. Health ministries and public payers in multiple countries are studying the Chinese model with direct policy interest.

Second, mini dental implant systems have established a tier of implant-supported prosthetic care that did not exist at scale a decade ago. MDIs — typically placed with flapless, minimally invasive protocols requiring no surgical incision or sutures — can stabilize a complete denture using two to four implants per arch at a fraction of the cost and surgical complexity of conventional implant rehabilitation. Clinical outcomes for MDI-supported overdentures are well documented: implant survival rates above 90 percent at five years, significant improvements in patient-reported quality of life and masticatory function, and retention of alveolar bone compared to conventional complete dentures.

Third, material advances in conventional complete dentures — particularly flexible thermoplastic base resins and advanced silicone soft liners — have meaningfully improved the comfort, retention, and service life of non-implant prosthetic options. For the majority of edentulous patients globally for whom any form of implant treatment remains financially out of reach, better conventional prosthetics represent an immediately actionable improvement in care quality.

Despite this convergence of clinical evidence and improving economics, global policy attention to edentulous rehabilitation remains strikingly disproportionate to the burden of disease.

The WHO's Global Oral Health Action Plan identifies edentulous populations as an underserved priority in both high-income and low-income countries. The action plan calls on member states to expand access to affordable complete denture services and to integrate oral health into broader noncommunicable disease and aging strategies. Implementation, however, has lagged far behind recommendation.

In most countries, dental care for elderly populations operates as an afterthought in health policy — poorly integrated with chronic disease management, dementia care, and nutrition programs that are directly affected by chewing function. The failure to treat edentulism as a systemic healthcare issue rather than an individual dental problem is reflected in the chronic underfunding of prosthetic dental services across nearly every health system globally.

Dentistry has developed extraordinary solutions for people who can access them. The problem is not clinical. The problem is that the world's 350 million edentulous patients are largely invisible to the health systems that should be serving them.

The path forward requires coordinated action across four domains simultaneously.

Workforce policy must expand the training and deployment of dental prosthetists and clinical dental technicians capable of delivering high-quality complete dentures and implant overdenture treatment. This requires not only more training slots but curricular reform that treats edentulous prosthetics as a core clinical competency rather than a historical craft skill.

Coverage policy must move beyond the question of whether to cover prosthetic dental services to the more urgent question of how to cover them in ways that incentivize quality, sustain provider capacity, and reach underserved populations. Tiered coverage models that provide baseline prosthetic access while allowing patients to purchase upgraded options create a sustainable framework that has proven effective in Germany, France, and multiple other European systems.